Ironwood Pharmaceuticals Inc (IRWD) with a beta value of 0.37 appears to be a promising investment opportunity.
On Monday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was -0.49% drop from the session before settling in for the closing price of $0.93. A 52-week range